The Vanderbilt-Ingram Cancer Center — Nashville, Tennessee

The Vanderbilt-Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

The Vanderbilt-Ingram Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Carcinoma, Small Cell, Small Cell Lung Cancer.

Sponsors: Merrimack Pharmaceuticals, Sunesis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Vanderbilt-Ingram Cancer Center?

The Vanderbilt-Ingram Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Vanderbilt-Ingram Cancer Center conducted?

The Vanderbilt-Ingram Cancer Center has 2 clinical trials on record. Their work covers Advanced Solid Tumors, Carcinoma, Small Cell, Small Cell Lung Cancer.

Is The Vanderbilt-Ingram Cancer Center accredited by Crixeo Health?

The Vanderbilt-Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Vanderbilt-Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.